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ABSTRACT 
Aim: we mainly aimed to elucidate potential comorbidities between celiac disease and hepatitis c by means of data and network 
analysis approaches. 
Background: understanding the association among the disorders evidently has important impact on the diagnosis and therapeutic 
approaches. Celiac disease is the most challenging, common types of autoimmune disorders. On the other hand, hepatitis c virus genome 
products like some proteins are supposed to be resemble to gliadin types that in turn activates gluten intolerance in people with inclined to 
gluten susceptibilities. Moreover, a firm support of association between chronic hepatitis and celiac disease remains largely unclear. 
Henceforth exploring cross-talk among these diseases will apparently lead to the promising discoveries concerning important genes and 
regulators.  
Methods: 321 and 1032 genes associated with celiac disease and hepatitis c retrieved from DisGeNET were subjected to build a gene 
regulatory network. Afterward a network-driven integrative analysis was performed to exploring prognosticates genes and related 
pathways.  
Results: 105 common genes between these diseases included 11 transcription factors were identified as hallmark molecules where by 
further screening enriched in biological GO terms and pathways chiefly in immune systems and signaling pathways such as 
chemokines, cytokines and interleukins.  
Conclusion: in silico data analysis approaches indicated that the identified selected combinations of genes covered a wide range of 
known functions triggering the inflammation implicated in these diseases. 
Keywords: celiac disease, hepatitis c, regulatory network. 
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Introduction  
  1 Celiac disease (CD), as a chronic immune-mediated 
disorder, is caused by gluten ingestion that exhibits a 
wide spectrum of clinical representations, including 
intestinal abnormalities and malabsorption (1). CD is a 
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genetic based disease with a 1% worldwide prevalence 
especially in western part of the world. Variety of 
manifestations like gut lesions are triggered by 
environment (gluten, infection, etc.) and genetic (HLA 
and non-HLA genes). CD is further characterized by 
severe autoimmune responses resulting in damaging 
small intestinal mucosa (1, 2). On the other hand, the 
hepatitis C virus (HCV) is a serious health burden 
which infects 170 million people globally that mostly 
asymptomatic in nature (3). Chronically infected 
patient’s present liver injury including liver cirrhosis 
ORIGINAL ARTICLE 
304  Celiac disease and hepatitis C network analysis 
 
Gastroenterol Hepatol Bed Bench 2017;10(4):303-310 
 
and liver failure (4). The remarkable ability of the virus 
to establish persistent infections (5-8), in addition to the 
poor understanding in pathogenesis of HCV, demands 
in-depth studies in elucidating HCV complex biological 
processes. Of note, being infected with HCV in long-
term definitely increases the risk of liver cancers such 
as hepatocellular carcinoma (HCC) (4). Although the 
most of CD patients indicated different gastrointestinal 
anomalies, they are also affected by several 
complications (9-12). Moreover several hepato- 
anomalies including cholangitis (14), hepatic T-cell 
lymphoma (14) as well as pancreatitis resulting in acute 
changes in endocrine system have been documented in 
symptomatic CD patients (14). CD-related changes in 
liver functions are thought to be due to the production 
of some agents like reactive oxygen species, tumor 
necrosis factor-α (TNF-α) and inflammatory responses.  
The complex molecular interactions underlying 
diseases demands the identification of biological units 
like transcription factors likewise the roadmap between 
different diseases. Considering the ever growing of 
omics data (15), data integration and analysis 
approaches are great keys for solving the disease’s 
complexities. In this study it was assumed that there is 
a sort of similarities among CD and HCV patients at 
the gene expression level. Therefore, networking was 
conducted to identify molecules underlying these 
disorders. The co-expressed genes that thought to have 
important influences in the pathogenesis of CD and 
HCV were then prioritized. Hereon, we attempted to 
provide a systematic understanding of the potential 
connections among these genes.   
 
Methods 
Firstly, curated gene-disease relations in CD and 
HCV was retrieved from DisGeNET v2.0 server 
(http://www.disgenet.org/web/DisGeNET). These sets 
has been collected from UNIPROT, human CTD, 
PsyGeNET, Orphanet and the HPO). Only disease-
related genes with at least one evidence from pfam was 
selected for further analysis. Afterward, a list of 9905 
regulatory links between human gene-transcription 
factors was obtained from TRRUST database 
(http://www.grnpedia.org/trrust/). These regulatory 
connections have been collected from 11,237 over 20 
million PubMed articles and experimentally validated 
transcriptional regulations consisting of 821 human 
transcription factors and 2,159 non-TF genes. 
Sentence-based text mining approach has been 
employed for seeking these interactions. Next, for 
illustrating regulatory interactions among the genes, a 
regulatory network was built using the intersection of 
CD and HCV assigned genes and regulatory links 
derived by TRRUST. The transcriptional regulatory 
links were further visualized by Cytoscape 3.4.0 
(http://www.cytoscape.org/). Genes within the network 
were separately ranked based on centrality statistics 
calculated by CytoNCA Cytoscape plugin (16). 
Pathway analysis was conducted on the inferred 
network using Reactom (http://reactome.org/). 
Additionally, GO biological terms were characterized 
by feeding the common genes in BINGO Cytoscape 
plugin (http://apps.cytoscape.org/apps/bingo). Finally, 
for elaborating the network of shared genes among CD-
HCV with biological regulators like miRNAs and 
discovering the experimentally validated miRNAs 
which interact with these genes, experimentally 
validated gene-miRNA interactions were taken from 
miRWalk 2.0 server (http://zmf.umm.uni-
heidelberg.de/apps/zmf/mirwalk2/miRpub.html) based 
on miRBase database.  
 
Results 
DisGeNET contains a list of diseases-associated 
genes collection based on the presence of genetic 
overlaps between diseases. In this list, among the 
4,753,986 potential diseases associations, 13,064 
diseases were found to share at least one gene. Among 
these disease-disease links, CD was significantly 
associated with arthritis, rheumatoid, atherosclerosis, 
multiple sclerosis and hepatitis C (combined score at P-
value < 0.05) from which, CD and HCV were 
significantly related with a high combined score and then 
selected for mining the common underlying genes. 
Combined score is computed by taking the log of the p-
value from the Fisher exact test and multiplying that by 
the z-score of the deviation from the expected rank. To 
this end, 321 and 1032 genes were retrieved from 
DisGeNET database, as CD and HCV specific genes 
respectively from which 105 gene were in common 
(figure 1). Among these 105 genes, CTNNB1, 
HNRNPD, NFKBIB, EGF, IRF1, IRF2, NFKB1,  
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Figure 1. Venn diagram of intersection between celiac disease, hepatitis c related genes retrieved from DisGeNET server and 
TRRUST regulatory links. Ultimately, 105 genes were taken as CD-HCV specific genes which are being in turn regulated by 
trascription factors based on the experimentally validated gene-TF links in TRRUST database. 
 
Figure 2. Interaction network established by common genes underlying celiac disease and hepatitis c. the green and red colors show genes and 
transcription factors respectively. Network units with more connectivity have been illustrated bigger.→ and ┴ arrows show the activation and 
repression effects of a TF on the targeted genes respectively. 
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FOXP3, STAT1, STAT3 and VDR were extracted as 
transcription factors by intersecting the list of 105 genes 
and 821 human transcription factors-genes interactions 
derived from TRRUST database. Afterward, 2607 
transcriptional relationships between these genes were 
exploited to establish a network (figure 2) by selecting 
the only highly ranked edges including EGF, IRF1, 
IRF2, NFKB1, FOXP3, STAT1, STAT3 and VDR 
transcription factors.  
In graph theory in addition to hub nodes (proteins 
with high degrees), certain nodes with higher centrality 
measures are more likely to be key connectors and 
likewise critical points controlling important dynamic 
components in biological networks (17) that removal of 
them causes biological systems fail to save their 
coherence. Hereby, in the generated network, NFKB1, 
STAT3, STAT1, IRF1, VDR and FOXP3 TFs, 
interleukin genes including IL10, IL6, IL2, IL2RA, 
epidermal growth factor receptor (EGFR), and interferon 
gamma (IFNG) showed the most connectivity. For 
adding a functional view to gene products within the 
regulatory network, functional classification was 
performed using BINGO Cytoscape plugin running 
hypergeometric test and Benjamini and Hochberg with 
False Discover Rate (FDR) correction at significant level 
0.01 (figure 3).  
 
 
Figure 3. Biological pathways in which common genes 
extracted from celiac disease and hepatitis c potentially 
involved by Reactom server with default parameters. The bars 
have been arranged top to down illustrating  the number of 
genes and significance level assigned to each pathway. 
According to the Figure 3, the genes were enriched in 
inflammatory response (STAT3, CLC2, FAS), apoptotic 
process (STAT1, CD14, IRF1) and MAPK cascade 
(EFGR, CCL5, CCR5, FGF1). Moreover in pathway 
analysis (figure 4), immune systems (innate and 
adaptive), mostly signaling pathways like chemokine, 
cytokine, interferon and interleukin1 were more 
noteworthy. Further study on the interplay in built 
network and microRNAs, was done by utilizing 
predicted miRNA-target networks from TargetScan 
(figure 5A) where miR-493, miR-23a/b miR-498, miR-
498 and miR-18b were taken as the potential regulators 
and  IRF1, FAS, IRF2, BCL2 and CTGF as their 
experimentally validated targets gathered from miRWalk 
(figure 5B). 
 
 
Figure 4. Functional classification of biological processes in 
which differential expressed genes from common genes 
associated to celiac disease and hepatitis c supposed to be 
involved. The GO terms considered significant based on 
hypergeometric test with Benjamini and Hochberg FDR 
correction and significance level 0.01 by BINGO app. The 
bars have been arranged top to down illustrating the number 
of genes and significance level assigned to each GO term. 
 
Discussion 
The co-incidence of two or more disorders in an 
individual is named comfortability, therefore 
characterizing genes and pathways involved in the 
related diseases would be helpful in identifying 
comorbidity patterns (18). The potential connections of 
CD and HCV has been extensively investigated in a 
number of studies (19-23). It is noteworthy that HCV 
may activate immune response to gluten in people with 
genetic susceptibility (24) that could be a fair 
explanation in comorbidity of CD and HCV (25). 
Thereof, as HCV initiates autoimmune disease process 
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and given the difficulty in determining interactions 
among the diseases, in the present study we employed 
freely available data and bioinformatics tools to 
investigate genes whose interactions is supposedly 
challenging in both of the CD and HCV pathogenesis 
and comorbidities. Among all possible 4,753,986 
disease associations annotated in DisGeNET database, 
CD was significantly related with HCV with P-value < 
0.05 and high combined score. Genetic overlap in gene 
ontology and pathway levels has been used to measure 
exploratory functions between two diseases in 
DisGeNET database.  Since HCV as an exogenous 
 
 
A: motif-miRNA interactions 
 
 
B: miRNA-target interactions 
 
 
Figure 5. A, interacting miRNAs with the upstream motifs in common genes underlying celiac disease and hepatitis 
c retrieved from TargetScan. B, experimentally validated targets of explored miRNAs using miRWalk. 
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cause of non-intestinal inflammatory responses is also 
able to induce immune systems (25), CD-HCV links 
was then chosen for investigating shared genetic 
components. Among the CD and HCV assigned genes, 
there are a number of interferon genes (IFNA1, IFNG) 
seemingly regulated by NFKB1, IFR1, STAT1 and 
STAT3 participating in inflammatory and apoptotic 
events (figures 2 and 3). Interestingly, interleukins were 
demonstrated as the most common genes regulated by 
all of the eight TFs in this study implying on 
indispensable role of interleukins in immune-mediated 
disorders. NFKB1 transcription factor with the highest 
centrality score within network, has the documented 
role in the regulation of interleukin genes (26). NFKB 
as a pivotal regulator of the adaptive immune system, 
modulates the activation, proliferation and survival of 
lymphocyte. NFKB pathway has been demonstrated to 
be constitutively upregulated in CD (27). In the core of 
NFKB signaling pathway, there are CD28 involved in 
proximal signaling, TNF, NOS2, STAT1, BCL and 
CLC all of them existed among the 105 common genes. 
As illustrated in the Figure 2, BLC2 is being 
suppressed by the most of transcription factors 
including VDR.  Another aspect of scrutinized genes 
was the abundance of Human leukocyte antigen (HLA-
A, HLA-G, HLA-DRB1) that are likely regulated by 
IRF1 and VDR in activating and unknown manners. 
HLA-mediated inflammatory reactions is thought to be 
linked with CD, HCV and other autoimmune disorders 
(28, 29) whereby a number of HLAs in this study were 
mainly regulated by IRF1 and VDR. IRF1 plays a role 
in triggering gluten intolerance that itself is being 
suppressed by STAT1 (figure 2). In this regard, FOXP3 
is essential to regulating differentiation of T-cells in 
adaptive immunity (30) activated and suppressed by 
NFKB1 and IRF1 respectively. VDR are normally 
expressed in the duodenal mucosa of patients with CD, 
causes mucosal damage (31). HLAs as predisposing 
genetic factors contributes to the genetic pathogeny of 
CD at 70%-95% (32, 33). Finally, to demonstrate the 
implications of miRNAs in CD-HCV, we have 
identified miRNAs relevant with CD and HCV. In the 
presented study based on the experimentally validated 
gene-miRNA interactions collected from miRWalk, 
miR-23a-3P, miR-18a-5p, miR-493, miR-498-5p, miR-
181/b-5p was found to regulated IRF1, FAS, IRF2, 
BCL2 and CTGF (figure 5). The dysregulation of miR-
23a/b have been already documented to be involved in 
several of chronic inflammations (34). Among them 
FAS is being likely activated by STAT3 (figure 2). 
FAS was indicated to be associated with the severity of 
atrophy in CD (35). FAS also was found to mediate cell 
apoptosis by contributing with IL10, interferon genes, 
T-cell receptors (CD94) and TNF-α (36). This could 
give a partial picture of initiating malignant and 
nonmalignant proliferation in T-cells due to the 
comorbidity of CD and HCV. Among the 105 genes, 
IL23A and CD28 have shown altered expression in 
both of children and adult people with CD and while 
STAT3 only was differentially expressed in adult (37).  
The absurdness of interleukin genes is still noteworthy 
considering inflammatory response (GO: 0006954), 
cytokine signaling, chemokines, interferon, interleukin 
signaling pathways (figures 4, 5). Interleukins and 
interferon have proven roles in Subsets of immune and 
inflammatory events against autoimmune diseases like 
CD (38). Among the interleukin genes, IL6 is 
seemingly repressed by NFKB1, VDR, STAT3 and 
STAT1. IL6 has shown altered expression only in adult 
with CD. TNF, IL2 and IL21 were exhibited to induce 
proliferation of innate intraepithelial lymphocytes (39) 
that are being activated and suppressed by STAT3 and 
VDR transcription factors respectively. Viral products 
have been thought to have a potential to trigger the 
development of CD in genetically inclined individuals 
(40, 41), however the findings of CD-HCV associations 
are still controversial (42-46). Nevertheless of these 
studies, bioinformatics analysis potentials has been less 
used in addressing more important genes with similar 
expression patterns in CD and HCV. Taken together, 
several of genes and transcription factors were 
highlighted which thought to interact to each other in 
giving rise to CD-HCV comorbidity principally via 
immune responses.   
However this analysis included some of limitations; we 
generated an unweighted network, we then should note 
the dynamic nature of diseases via strictly analysis of 
static networks. Furthermore CD and HCV related 
genes were retrieved from adult and children forms of 
CD as well as all forms of HCV either acute, chronic 
and HCV-related hepatocellular carcinoma while CD 
can appear at any age but there are some differences in 
CD in children and adult form of CD. One therefore 
should be more specific to drive the exact types of 
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disease-disease links using the strict criterion. Utilizing 
CD and HCV trade-off can help to explain disease 
inverse comorbidity. We noticed that CD-HCV specific 
genes were mainly assigned to pathways explicating the 
inflammation responses. Apparently the immune 
system reactions to each of them contribute to the 
activation in the setting of antibodies that in turn will 
cause of new symptoms even involved. Functional 
classification of common genes mainly in chemokine 
and cytokine pathways might be biologically relevant 
with the necessity of screening disease-associated 
antibodies prior to the therapies for declining 
inflammatory responses in these patients. 
In conclusion, conserved genes and TFs obtained by 
network-based analysis like NFKB1, STAT3, IRF1, 
HLAs interleukin genes and chemokines could be 
proposed for future researches where their interactions 
could be proofed by confidently experiments. 
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